China Animal Vaccine Industry Report, 2009-2010
  • Jun.2010
  • Hard Copy
  • USD $1,400
  • Pages:65
  • Single User License
    (PDF Unprintable)       
  • USD $1,500
  • Code: ZYM007
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,250
  • Hard Copy + Single User License
  • USD $1,600
      

China’s animal vaccine market has grown up steadily despite all the twists and turns in the livestock and poultry breeding market over the past four years. In 2009, the market scale reached around RMB6.2 billion, up 14.8% year-on-year, and will keep expanding with the development of the livestock and poultry breeding market.

China’s Animal Vaccine Market Scale and Y-o-Y Growth, 2006-2009 (Unit: RMB bn)
 2010062201.gif 
Source: ResearchInChina

Restricted by people’s living habits and economic conditions, animal vaccine R&D and production in China mainly focuses on economic animal vaccines. In the meantime, the development of traditional national compulsory vaccines such as foot and mouth disease vaccine, bird flu vaccine, blue ear disease vaccine, hog cholera vaccine in China are relatively mature as a result of national animal vaccine procurement policies. In 2009, the compulsory vaccines accounted for over 86% shares in the entire animal vaccine market, which was basically shared by domestic companies. China Animal Husbandry Industry Co., Ltd. (CAHIC), Yebio Bioengineering Co., Ltd. (Yebio QD), Inner Mongolia Jinyu Group Co., Ltd. (Jinyu Group), Harbin Pharmaceutical Group Bio-vaccine Co., Ltd. (formerly “The First Bio-product Manufactory of Heilongjiang Province”) and Xinjiang Tecon Animal Husbandry Bio-technology Co., Ltd. (Tecon) accounted for 40.7% shares. However, commercial animal vaccines, pet vaccines in particular, had a higher dependence on import. Imported pet vaccines approximately accounted for 70% of total domestic market sales value, and 30% of total domestic market sales volume.

Market Shares of China’s Key Animal Vaccine Manufacturers by Sales, 2009 
 2010122010.gif
Source: ResearchInChina

Besides the operating environment, development status, market scale, supply & demand, competition, import & export and development prospect of China’s animal vaccine industry, the report also made an in-depth analysis of the development, market scale, and development trend of global animal vaccine industry, as well as the operation, development prospect and advantages of China’s key animal vaccine manufacturers.

1. Animal Vaccine Overview 
1.1 Definition & Classification of Animal Vaccines 
1.2 Definition & Classification of Animal Biological Products 

2. Animal Vaccine Industry Operating Environment 
2.1 Macro Environment 
2.2 Policy Environment 
2.3 Social Environment 

3. Global Animal Vaccine Industry 
3.1 Overview 
3.2 Market Scale 
3.3 Key Countries and Regions 
3.3.1 USA 
3.3.2 Europe
3.4 Development Prospect 

4. China’s Animal Vaccine Industry 
4.1 Overview 
4.2 Market Scale 
4.3 Supply & Demand 
4.4 Competition 
4.5 Import & Export 
4.5.1 Export 
4.5.2 Import 
4.6 Development Prospect 

5. Animal Vaccine Market Segments in China 
5.1 Swine Vaccines 
5.2 Poultry Vaccines  
5.3 Cattle & Sheep Vaccines  
5.4 Pet Vaccines 

6. Key Manufacturers 
6.1 CAHIC
6.1.1 Company Profile
6.1.2 Operation
6.1.3 Animal Vaccine Business
6.1.4 Animal Vaccine Business Development Prospect & Advantages
6.2 Jinyu Group
6.2.1 Company Profile
6.2.2 Operation
6.2.3 Animal Vaccine Business
6.2.4 Animal Vaccine Business Development Prospect & Advantages
6.3 Tecon
6.3.1 Company Profile
6.3.2 Operation
6.3.3 Animal Vaccine Business
6.3.4 Animal Vaccine Business Development Prospect
6.4 Ningbo Tech-Bank
6.4.1 Company Profile
6.4.2 Operation
6.4.3 Chengdu Tech-Bank (formerly Chengdu Jinghua)
6.5 Shenghua Biok 
6.5.1 Company Profile
6.5.2 Operation
6.5.3 Yebio QD
6.6 Huasun Group 
6.6.1 Company Profile
6.6.2 Operation
6.6.3 Sichuan Huasun 
6.7Harbin Pharmaceutical Group
6.7.1 Company Profile
6.7.2 Animal Vaccine Business Status Quo & Prospect 
6.8 Foreign Manufacturers in China  
6.8.1 Merial
6.8.2 Boehringer-Ingelheim
6.8.3 Bayer
6.8.4 Novartis
Animal Vaccine Types and Characteristics 
China’s GDP Growth Margin Changes, 2007-2010Q1 
China’s Meat, Poultry & Egg and Milk Output, 2007-2009 
World’s Animal Vaccine Output Value Distribution, 2008 
World’s Animal Vaccine Market Structure by Animal Species, 2009 
World’s Animal Vaccine Market Scale, 2004, 2008 & 2009 
U.S. Animal Vaccine Product Structure by Animal Species, 2009 
U.S. Main Animal Vaccines Output, 2008 
U.S. Various Animal Vaccines Y-o-Y Changes, 2008 
U.S. Main Animal Vaccine Product Types, 2008 
European Animal Vaccine Product Structure, 2009 
China’s Animal Vaccine Market Share by Category, 2009 
China’s Animal Vaccine Industry Market Scale & Growth, 2006-2009 
China’s Key Animal Vaccine Manufacturers 
Production of China’s Key Animal Vaccine Manufacturers 
China’s Animal Vaccine Consumption Structure by Animal Species, 2009 
China’s Animal Vaccination Program, 2010 
Market Shares of China’s Main Animal Vaccine Manufacturers by Sales, 2009 
Quantity of Manufacturers of Key Leading Companies in Government Animal Vaccine Procurement, 2009 
China’s Animal Vaccine Export Volume, Value and Average Unit Price, 2007-2009 
China’s Animal Vaccine Oversea Market Distribution, 2009 
China’s Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2009 
Origins of China’s Imported Animal Vaccines, 2009 
China’s Animal Vaccine Industry Development Driving Forces 
China’s Animal Vaccine Market Scale, 2010 
China’s Pig Inventory and Slaughter Quantity, 2000-2009 
China’s Pig Vaccine Market Scale, 2008-2009 
Performance Comparison of China’s Various Hog Cholera Vaccines 
China’s Poultry Vaccine Market Scale, 2008-2009 
Ratio of China’s Poultry Vaccine by Category, 2009 
Cattle & Sheep Vaccine Market Scale, 2008-2009 
Foot and Mouth Disease in China, 2009 
China’s Pet Vaccine Market Scale, 2008-2010 
China’s Pet Vaccine Suppliers 
CAHIC Operating Income and Net Income, 2007-2010Q1 
CAHIC Operating Profit Margin Change, 2007-2009 
CAHIC Operating Income & Structure, 2007-2009 
CAHIC Operating Income by Region, 2009 
CAHIC Animal Vaccine Output Capacity Distribution 
CAHIC Animal Vaccine Sales Ratio by Category, 2007-2009 
CAHIC Compulsory Vaccine and Market- oriented Vaccine Ratios, 2009  
CAHIC Compulsory Vaccine Ratio by Category, 2009 
CAHIC Animal Vaccine Gross Profit, 2007-2009 
Jinyu Group Operating Income and Net Income, 2007-2010Q1 
Jinyu Group Operating Income & Structure, 2007-2009 
Jinyu Group Operating Profit Margin Change, 2007-2009 
Jinyu Group Operating Income by Region, 2009 
Jinyu Group Animal Vaccine Output Capacity Distribution 
Jinyu Group Operating Income and Gross Profit Margin Change, 2007-2009 
Tecon Operating Income and Net Income, 2007-2010Q1 
Tecon Operating Income and Structure, 2007-2009 
Tecon Operating Profit Margin Change, 2007-2009 
Ratio of Tecon R&D Input to Operating Income, 2007-2009 
Tecon Operating Income by Region, 2009 
Tecon Animal Vaccine Income and Gross Profit Margin Changes, 2007-2009 
Ningbo Tech-Bank Operating Income and Net Income, 2008-2010Q1 
Ningbo Tech-Bank Operating Income and Structure, 2008-2009 
Ningbo Tech-Bank Main Product Gross Profit Margin Changes, 2008-2009 
Chengdu Tech-Bank Animal Vaccine Income Structure, 2009 
Shenghua Biok Operating Income and Net Income, 2007-2009 
Shenghua Biok Main Business Revenue and Structure, 2007-2009
Shenghua Biok Operating Margin Change, 2007-2009 
Yebio QD Operating Income and Net Income, 2008-2009
Huasun Group Operating Income and Net Income, 2007-2009 
Huasun Group Operating Income and Structure, 2008-2009
Huasun Group Gross Profit Margin Change, 2007-2009 

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号
在线客服系统